Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

诺氟沙星胶囊 - NMPA Drug Approval Details

Approvals/NMPA/Norfloxacin Capsules

Approved

化学药品

Norfloxacin Capsules

浙江金湖药业有限公司🇨🇳 National Medical Products Administration

Approval Date: Apr 26, 2011
Approval ID: 800bD5PyrJC
Company: 浙江金湖药业有限公司
Type: 化学药品

Approval Details

Approval Id: 800bD5PyrJC
Approval Number: 国药准字H34021833
Generic Name: 诺氟沙星胶囊
Generic Name En: Norfloxacin Capsules
Drug Type: 化学药品
Strength: 0.1g
Reg Date: 2011-04-26
Company Name: 浙江金湖药业有限公司
Production Company Address: 浙江省平湖经济开发区独黎路北侧兴平二路东侧
Company Detail Path: /organization/zhe-jiang-jin-hu-yao-ye-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Apr 26, 2011

Approval ID

800bD5PyrJC

Type

化学药品

Back to NMPA Approvals